Molecular signatures of ovarian diseases: Insights from network medicine perspective

Systems Biology in Reproductive Medicine

Volumn 62, Issue 4, 2016, Pages 266-282

  Kori, Medi ^a   Gov, Esra ^a   Arga, Kazim Yalcin ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Ovarian cancer; ovarian endometriosis; polycystic ovarian syndrome; reporter biomolecules; therapeutic targets

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; COX17 PROTEIN; CYCLINE; CYTOCHROME C; ELAV LIKE PROTEIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE DEACETYLASE 5; HISTONE H2A; INTERCELLULAR ADHESION MOLECULE 1; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROSTACYCLIN; PROTEIN; PROTEIN FOS; PROTEIN P53; PSPC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SELENOMETHIONINE; SIRTUIN 7; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT1 PROTEIN; STAT6 PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; PROTEOME;

ARTICLE; ENDOMETRIOSIS; GENE EXPRESSION; OVARY CANCER; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; FEMALE; GENETICS; HUMAN; META ANALYSIS; METABOLISM; MOLECULAR DIAGNOSIS; OVARY TUMOR;

BIOMARKERS; FEMALE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR DIAGNOSTIC TECHNIQUES; OVARIAN DISEASES; OVARIAN NEOPLASMS; PROTEOME; TRANSCRIPTOME;

EID: 84976385302     PISSN: 19396368     EISSN: 19396376     Source Type: Journal    
DOI: 10.1080/19396368.2016.1197982     Document Type: Article

References (125)

1. M.T.Anam, A.Ishika, M.B.Hossain, and Jesmin (2015) A meta-analysis of hypoxia inducible factor 1-alpha (HIF1A) gene polymorphisms: association with cancers. Biomark Res 3: 29.
2. J.B.Aragon-Ching, (2014) The evolution of prostate cancer therapy: targeting the androgen receptor. Front Oncol 4: 295.
3. W.Atiomo, and C.A.Daykin, (2012) Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study. Mol Hum Reprod 18(11): 546–553.
4. S.Aviel-Ronen, D.Soriano, E.Shmuel, R.Schonman, K.Rosenblatt, O.Zadok, et al. (2014) Surgically treated ovarian endometriosis association with BRCA1 and BRCA2 mutations. Pathol Res Pract 210(4): 250–255.
5. H.M.Awwad, J.Geisel, and R.Obeid, (2012) The role of choline in prostate cancer. Clin Biochem 45(18): 1548–1553.
6. R.Azziz, E.Carmina, D.Dewailly, E.Diamanti-Kandarakis, H.F.Escobar-Morreale, W.Futterweit, et al. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2): 456–488.
7. M.A.Bain, R.Faull, G.Fornasini, R.W.Milne, and A.M.Evans, (2006) Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 21(5): 1300–1304.
8. A.L.Barabási, N.Gulbahce, and J.Loscalzo, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1): 56–68.
9. T.Barrett, S.E.Wilhite, P.Ledoux, C.Evangelista, I.F.Kim, M.Tomashevsky, et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41: 991–995.
10. K.G.Becker, K.C.Barnes, T.J.Bright, and S.A.Wang, (2004) The genetic association database. Nat Genet 36(5): 431–432.
11. R.Beckerman, and C.Prives, (2010) Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2(8): a000935.
12. P.Bellelis, S.Podgaec, and M.S.Abrao, (2011) Environmental factors and endometriosis. Rev Assoc Med Bras 57(4): 448–452.
13. C.Bento, M.K.Andersson, and P.Aman, (2009) DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2. BMC Cell Biol 10:89.
14. S.Bernatsky, R.Ramsey-Goldman, J.Labrecque, L.Joseph, J.F.Boivin, M.Petri, et al. (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130-135.
15. L.Bodnar, A.Stanczak, S.Cierniak, M.Smoter, M.Cichowicz, W.Kozlowski, et al. (2014) Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer. J Ovarian Res 7:16.
16. B.M.Bolstad, R.A.Irizarry, M.Astrand, and T.P.Speed, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2): 185–193.
17. N.J.Bowen, L.D.Walker, L.V.Matyunina, S.Logani, K.A.Totten, B.B.Benigno, et al. (2009) Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 29(2):71.
18. B.Calimlioglu, K.Karagoz, T.Sevimoglu, E.Kilic, E.Gov, and K.Y.Arga, (2015) Tissue-specific molecular biomarker signatures of Type 2 Diabetes: An integrative analysis of transcriptomics and protein–protein interaction data. OMICS 19(9): 563–573.
19. M.C.Cathcart, S.G.Gray, A.M.Baird, E.Boyle, K.Gately, E.Kay, et al. (2011) Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer. Cancer 117(22): 5121–5132.
20. M.Chagoyen, and F.Pazos, (2011) MBRole: enrichment analysis of metabolomic data. Bioinformatics 27(5):730–731.
21. C.Chang, S.O.Lee, R.S.Wang, S.Yeh, and T.M.Chang, (2013a). Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells. Biol Reprod 89(1): 1–16.
22. J.H.Chang, H.K.Au, W.C.Lee, C.C.Chi, T.Y.Ling, L.M.Wang, et al. (2013b) Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril 99(5):1332–1339.
23. L.Chen, S.Wang, Y.Zhou, X.Wu, I.Entin, J.Epstein, et al. (2010) Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma. Blood 115(1): 61–70.
24. Y.F.Chen, Y.T.Chen, W.T.Chiu, and M.R.Shen, (2013) Remodeling of calcium signaling in tumor progression. J Biomed Sci 20: 23.
25. Y.Chi, and A.A.Sauve, (2013) Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr Opin Clin Nutr Metab Care 16(6): 657–661.
26. A.Chiarugi, C.Dölle, R.Felici, and M.Ziegler, (2012) The NAD metabolome–a key determinant of cancer cell biology. Nat Rev Cancer 12(11): 741–752.
27. B.G.Chittenden, G.Fullerton, A.Maheshwari, and S.Bhattacharya, (2009) Polycystic ovary syndrome and the risk of gynecological cancer: a systematic review. Reprod Biomed Online 19(3): 398–405.
28. H.Clevers, and R.Nusse, (2012) Wnt/β-catenin signaling and disease. Cell 149(6): 1192–1205.
29. V.Desai, N.R.Prasad, S.M.Manohar, A.Sachan, S.R.Narasimha, and A.R.Bitla, (2014) Oxidative stress in non-obese women with polycystic ovarian syndrome. J Clin Diagn Res 8(7): 1–3.
30. J.Didžiapetrienė, J.Bublevič, G.Smailytė, B.Kazbarienė, and R.Stukas, (2014) Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients. Medicana 50: 204–208.
31. J.Dittmer, (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2:29.
32. N.Filigheddu, I.Gregnanin, P.E.Porporato, D.Surico, B.Perego, L.Galli, et al. (2010) Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol 2010: 369549.
33. M.Y.Fong, J.McDunn, and S.S.Kakar, (2011) Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One 6(5): e19963.
34. M.Gabay, Y.Li, and D.W.Felsher, (2014) MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med 4(6): a014241.
35. M.Garcia-Albornoz, S.Thankaswamy-Kosalai, A.Nilsson, L.Varemo, I.Nookaew, and J.Nielsen, (2014) BioMet Toolbox 2.0: genome-wide analysis of metabolism and omics data. Nucleic Acids Res 42:175-181.
36. T.A.Gatcliffe, B.J.Monk, K.Planutis, and R.F.Holcombe, (2008) Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 18(5): 954–962.
37. S.Gatt, and A.Dagan, (2012) Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chem Phys Lipids 165(4): 462–474.
38. L.Gautier, L.Cope, B.M.Bolstad, and R.A.Irizarry, (2004) Affy- analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3): 307–315.
39. R.C.Gentleman, V.J.Carey, D.M.Bates, B.Bolstad, M.Dettling, S.Dudoit, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10): 80.
40. F.Gibellini, and T.K.Smith, (2010) The Kennedy pathway–De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62(6): 414–428.
41. S.Govatati, K.Challa, S.B.Reddy, K.Pramod, M.Deenadayal, B.Chakravarty, et al. (2014) BRCA1 alterations are associated with endometriosis, but BRCA2 alterations show no detectable endometriosis risk: a study in Indian population. J. Assist. Reprod Genet 32(2): 277–285.
42. S.Goyama, J.Schibler, L.Cunningham, Y.Zhang, Y.Rao, and N.Nishimoto, (2013) Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 123(9): 3876–3888.
43. H.R.Harris, D.W.Cramer, A.F.Vitonis, M.DePari, and K.L.Terry, (2012) Folate, vitamin B6, vitamin B12, methionine and alcohol intake in relation to ovarian cancer risk. Int J Cancer 131(4): 518–529.
44. S.L.Harris, and A.J.Levine, (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24(17): 2899–2908.
45. S.Hatakeyama, (2011) TRIM proteins and cancer. Nature Reviews Cancer 11: 792–804.
46. J.Hayes, P.P.Peruzzi, and S.Lawler, (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20(8): 460–469.
47. A.Hever, R.B.Roth, P.Hevezi, M.E.Marin, J.A.Acosta, H.Acosta, et al. (2007) Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A 104(30): 12451–12456.
48. S.Hira, T.Tomita, T.Matsui, K.Igarashi, and M.Ikeda-Saito, (2007) Bach1, a heme-dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure. IUBMB Life 59(8–9): 542–551.
49. S.D.Hsu, Y.T.Tseng, S.Shrestha, Y.L.Lin, A.Khaleel, C.H.Chou, et al. (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids 42: 78–85.
50. D.W.Huang, B.T.Sherman, and R.A.Lempicki, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1): 1–13.
51. J.E.Hutti, R.R.Shen, D.W.Abbott, A.Y.Zhou, K.M.Sprott, J.M.Asara, et al. (2009) Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKK-epsilon promotes cell transformation. Mol Cell 34: 461–472.
52. M.V.Iorio, R.Visone, G.Di Leva, V.Donati, F.Petrocca, P.Casalini, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67(18): 8699–8707.
53. R.Iwanaga, H.Komori, S.Ishida, N.Okamura, K.Nakayama, K.I.Nakayama, et al. (2006) Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners. Oncogene 25(12): 1786–798.
54. L.Jiang, J.Huang, L.Li, Y.Chen, X.Chen, X.Zhao, et al. (2015) MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab 100(5): 729–738.
55. J.Johansson, and E.Stener-Victorin, (2013) Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med 2013: 762615.
56. M.Kanehisa, S.Goto, Y.Sato, M.Kawashima, M.Furumich, and M.Tanabe, (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42: 199–205.
57. K.Karagoz, R.Sinha, and K.Y.Arga, (2015) Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways. OMICS 19(2): 115–130.
58. C.Ke, Y.Hou, H.Zhang, L.Fan, T.Ge, B.Guo, et al. (2015) Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer 136(3): 516–526.
59. S.Kenigsberg, Y.Bentov, V.Chalifa-Caspi, G.Potashnik, R.Ofir, and O.S.Birk, (2009) Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod 15(2): 89–103.
60. J.Kim, H.S.Kang, Y.J.Lee, H.J.Lee, J.Yun, J.H.Shin, et al. (2014) EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Cancer Lett 349(1): 35–44.
61. S.G.Lamarre, G.Morrow, L.Macmillan, M.E.Brosnan, and J.T.Brosnan, (2013) Formate: an essential metabolite, a biomarker, or more? Clin Chem Lab Med 51(3): 571–578.
62. P.Laudanski, R.Charkiewicz, M.Kuzmicki, J.Szamatowicz, A.Charkiewicz, and J.Niklinski, (2013) MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis. Reprod Biol Endocrinol 11: 78.
63. H.Li, S.Xie, M.Liu, Z.Chen, X.Liu, L.Wang, et al. (2014) The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 45(1): 197–208.
64. M.Ligr, R.R.Patwa, G.Daniels, L.Pan, X.Wu, Y.Li, et al. (2011) Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer. PLoS One 6(10): e26250.
65. S.Liu, X.Zhang, C.Shi, J.Lin, G.Chen, B.Wu, et al. (2015) Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome. J Transl Med 13: 238.
66. M.Llauradó, M.Abal, J.Castellví, S.Cabrera, A.Gil-Moreno, A.Pérez-Benavente, et al. (2012) ETV5 transcription factor is over-expressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells. Int J Cancer 130(7): 1532–1543.
67. Y.Y.Lu, W.J.Zhu, and B.G.Xie, (2014) Von Hippel-Lindau gene expression in human endometrium during menstrual cycle. Mol Med Rep 9(4): 1355–1358.
68. P.R.Manna, and D.M.Stocco, (2011) The Role of Specific Mitogen-Activated Protein Kinase Signaling Cascades in the Regulation of Steroidogenesis. J Signal Transduct 2011: 821615.
69. A.Mardinoglu, R.Agren, C.Kampf, A.Asplund, M.Uhlen, and J.Nielsen, (2014) Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun 5: 3083.
70. L.K.McGinnis, W.H.Kinsey, and D.F.Albertini, (2009) Functions of Fyn kinase in the completion of meiosis in mouse oocytes. Dev Biol 327(2): 280–287.
71. L.M.McGlynn, S.McCluney, N.B.Jamieson, J.Thomson, A.I.MacDonald, K.Oien, et al. (2015) SIRT3 & SIRT7: Potential novel biomarkers for determining outcome in pancreatic cancer patients. PLoS One 10(6): e0131344.
72. G.F.Meresman, and C.N.Olivares, (2012) Involvement of Prostaglandins in the Pathophysiology of Endometriosis. In Endometriosis - Basic Concepts and Current Research Trends ed. by K.Chaudhury, and B.Chakravarty, InTech, Croatia. pp. 115–132.
73. L.Miles, M.V.Miles, P.H.Tang, P.S.Horn, J.G.Quinlan, B.Wong, et al. (2005) Ubiquinol: a potential biomarker for tissue energy requirements and oxidative stress. Clin Chim Acta 360(1–2): 87–96.
74. E.Mills, and L.A.O’Neill, (2014) Succinate: a metabolic signal in inflammation. Trends Cell Biol 24(5): 313–320.
75. T.J.Mitchell, and S.John, (2005) Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 114(3): 301–312.
76. G.L.Moldovan, B.Pfander, and S.Jentsch, (2007) PCNA, the maestro of the replication fork. Cell 129: 665–679.
77. C.S.Moreno, L.Matyunina, E.B.Dickerson, N.Schubert, N.J.Bowen, S.Logani, et al. (2007) Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PLoS One 2(5): e441.
78. L.Mu, W.Zheng, L.Wang, X.Chen, and J.Yang (2008) Focal adhesion kinase expression in ovarian endometriosis. Int J Gynaecol Obstet 101(2): 161–165.
79. U.Mudunuri, A.Che, M.Yi, and R.M.Stephens, (2009) bioDBnet: the biological database network. Bioinformatics 25: 555–556.
80. C.Muñoz-Pinedo, N.El Mjiyad, and J.E.Ricci, (2012) Cancer metabolism: current perspectives and future directions. Cell Death Dis 3(1): e248.
81. N.S.Nagaraj, and P.K.Datta, (2010) Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs 19(1): 77–91.
82. G.G.Nahum, A.M.Kaunitz, K.Rosen, T.Schmelter, and R.Lynen, (2015) Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system. Contraception 91(5): 412–417.
83. S.L.Neuberg, D.T.Kenrick, and M.Schaller, (2011) Human threat management systems: self-protection and disease avoidance. Neurosci Biobehav Rev 35(4): 1042–1051.
84. N.Nishikawa, M.Toyota, H.Suzuki, T.Honma, T.Fujikane, T.Ohmura, et al. (2007) Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res 67(20): 9649–9657.
85. D.W.Nyman, M.Suzanne Stratton, M.J.Kopplin, B.L.Dalkin, R.B.Nagle, and A.Jay Gandolfi, (2004) Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev 28(1): 8–16.
86. Z.Oksuz, M.S.Serin, E.Kaplan, A.Dogen, S.Tezcan, G.Aslan, et al. (2015) Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Mol Biol Rep 42(3): 713–720.
87. I.Ortega, and A.J.Duleba, (2013) Polycystic Ovary Syndrome: Current and Emerging Concepts: Role of Statins. In PCOS Management ed. L.Pal, Springer Science, New York. pp. 182–203.
88. K.R.Patil, and J.Nielsen, (2005) Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci U S A 102(8): 2685–2689.
89. M.E.Pavone, and B.M.Lyttle, (2015) Endometriosis and ovarian cancer: links, risks, and challenges faced. Int J Womens Health 7: 663–672.
90. H.Pópulo, J.M.Lopes, and P.Soares, (2012) The mTOR signalling pathway in human cancer. Int J Mol Sci 13(2): 1886–1918.
91. E.Portales-Casamar, D.Arenillas, J.Lim, M.I.Swanson, S.Jiang, A.McCallum, et al. (2009) The PAZAR database of gene regulatory information coupled to the ORCA toolkit for the study of regulatory sequences. Nucleic Acids Res 37: 54–60.
92. J.Prat, (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet 124: 1–5.
93. C.S.Pundir, and R.Devi, (2014) Biosensing methods for xanthine determination: a review. Enzyme Microb Technol 10(57): 55–62.
94. R.P.Rao, N.Vaidyanathan, M.Rengasamy, A.M.Oommen, N.Somaiya, and M.R.Jagannath, (2013) Sphingolipid Metabolic Pathway: An Overview of Major Roles Played in Human Diseases. J Lipids 2013: 178910.
95. J.S.Richards, and S.A.Pangas, (2010) The ovary: basic biology and clinical implications. J Clin Invest 120(4): 963–972.
96. Y.D.Saito, A.R.Jensen, R.Salgia, M.Edwin and E.M.Posadas, (2010) Fyn: a novel molecular target in prostate cancer. Cancer 116(7): 1629–1637.
97. J.A.Sampson, (1925) Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 10(1).
98. A.Sayasneh, D.Tsivos, and R.Crawford, (2011) Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gynecol 2011:140310.
99. E.Schmukler, and R.Ronit Pinkas-Kramarski (2015) Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging: Role in Human Diseases ed. Hayat, M.A., Elsevier Inc., MA. pp. 65–80.
100. E.Sedlák, M.Fabian, N.C.Robinson, and A.Musatov, (2010) Ferricytochrome c protects mitochondrial cytochrome c oxidase against hydrogen peroxide-induced oxidative damage. Free Radic Biol Med 49(10): 1574–1581.
101. B.Sen, and F.M.Johnson, (2011) Regulation of SRC family kinases in human cancers. J Signal Transduct 2011: 865819.
102. T.Sevimoglu, and K.Y.Arga, (2015) Computational systems biology of psoriasis: Are we ready for the age of omics and systems biomarkers? OMICS 19(11): 669–687.
103. Y.Shi, and J.Massague, (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685–700.
104. P.G.Signorile, and A.Baldi, (2015) New evidence in endometriosis. Int J Biochem Cell Biol 60: 19–22.
105. S.Simoens, L.Hummelshoj, and T.D’Hooghe, (2007) Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 13(4): 395–404.
106. M.E.Smoot, K.Ono, J.Ruscheinski, P.L.Wang, and T.Ideker, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3): 431–432.
107. G.K.Smyth, (2005) Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor. eds. R.Gentleman, V.Carey, S.Dudoit, R.Irizarry, W.Huber, (eds), Springer, NY pp. 397–420.
108. A.E.Sørensen, M.L.Wissing, S.Salö, A.L.M.Englund, and L.T.Dalgaard, (2014) MicroRNAs related to polycystic ovary syndrome (PCOS). Genes 5: 684–708.
109. V.L.Stevens, M.L.McCullough, A.L.Pavluck, J.T.Talbot, H.S.Feigelson, M.J.Thun, et al. (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 16(6): 1140–1147.
110. I.Stoimenov, and T.Helleday, (2009) PCNA on the crossroad of cancer. Biochem Soc Trans 37: 605–613.
111. H.L.Su, and S.S.Li, (2002) Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 296(1–2): 65–73.
112. B.Sun, and H.Jiang, (2012) An efficient approach for total synthesis of aminopropyl functionalized ganglioside GM1b. Tetrahedron Lett 53(42): 5711–5715.
113. A.Vazquez, J.Liu, Y.Zhou, and Z.N.Oltvai, (2010) Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited. BMC Syst Biol 4:58.
114. K.Vouk, N.Hevir, M.Ribić-Pucelj, G.Haarpaintner, H.Scherb, J.Osredkar, et al. (2012) Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod 27(10): 2955–2965.
115. H.L.Wang, R.Q.Lu, S.H.Xie, H.Zheng, X.M.Wen, X.Gao, et al. (2015) SIRT7 exhibits oncogenic potential in human ovarian cancer cells. Asian Pac J Cancer Prev 16(8): 3573–3577.
116. J.M.Whitworth, A.I.Londoño-Joshi, J.C.Sellers, P.J.Oliver, D.D.Muccio, V.R.Atigadda, et al. (2012) The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells. Gynecol Oncol 125(1): 226–230.
117. A.C.Wilson, S.V.Meethal, R.L.Bowen, and C.S.Atwood, (2007) Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs 16(11): 1851–1863.
118. J.R.Wood, V.L.Nelson-Degrave, E.Jansen, J.M.McAllister, S.Mosselman, and J.F.Strauss, 3rd (2005) Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics 20(3): 233–243.
119. J.Xue, X.Lin, W.T.Chiu, Y.H.Chen, G.Yu, M.Liu, et al. (2014) Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β–dependent cancer metastasis. J Clin Invest 124(2): 564–579.
120. Y.Yang, N.Hou, X.Wang, L.Wang, S.Chang, K.He, et al. (2015) miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Oncotarget 6(18): 16227–16238.
121. Z.Yang, M.He, K.Wang, G.Sun, L.Tang, and Z.Xu, (2014) Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. Int J Clin Exp Pathol 7(11): 7563–7570.
122. X.Ye, and J.Chun, (2010) Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends Endocrinol Metab 21(1): 17–24.
123. D.Yu, M.Kim, G.Xiao, and T.H.Hwang, (2013) Review of biological network data and its applications. Genomics Inform 11(4): 200–210.
124. J.Zhang, Y.Song, C.Zhang, X.Zhi, H.Fu, Y.Ma, et al. (2015) Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Theranostics 5(7): 733–745.
125. L.Zhang, W.Liu, Q.Hao, L.Bao, and K.Wang, (2012) Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk. Int J Mol Sci 13(4): 4009–4020.